vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Lake Shore Bancorp, Inc. (LSBK). Click either name above to swap in a different company.

Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $7.4M, roughly 1.1× Lake Shore Bancorp, Inc.). Lake Shore Bancorp, Inc. runs the higher net margin — 31.8% vs -766.0%, a 797.8% gap on every dollar of revenue. Lake Shore Bancorp, Inc. produced more free cash flow last quarter ($3.3M vs $-63.9M).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Lake Shore Bancorp, Inc. (Maryland) is a U.S. regional bank holding company that operates via its banking subsidiary, offering retail and commercial banking services including deposits, loans, mortgages and wealth management, primarily serving individuals and SMEs across local communities in Maryland.

ACLX vs LSBK — Head-to-Head

Bigger by revenue
ACLX
ACLX
1.1× larger
ACLX
$8.1M
$7.4M
LSBK
Higher net margin
LSBK
LSBK
797.8% more per $
LSBK
31.8%
-766.0%
ACLX
More free cash flow
LSBK
LSBK
$67.2M more FCF
LSBK
$3.3M
$-63.9M
ACLX

Income Statement — Q1 FY2025 vs Q3 FY2025

Metric
ACLX
ACLX
LSBK
LSBK
Revenue
$8.1M
$7.4M
Net Profit
$-62.3M
$2.4M
Gross Margin
Operating Margin
-847.6%
38.4%
Net Margin
-766.0%
31.8%
Revenue YoY
-79.3%
Net Profit YoY
-765.1%
EPS (diluted)
$-1.13
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
LSBK
LSBK
Q3 25
$7.4M
Q2 25
$6.9M
Q1 25
$8.1M
Q4 24
$15.3M
Q3 24
$26.0M
Q2 24
$27.4M
Q1 24
$39.3M
Q4 23
$63.1M
Net Profit
ACLX
ACLX
LSBK
LSBK
Q3 25
$2.4M
Q2 25
$1.9M
Q1 25
$-62.3M
Q4 24
$-47.1M
Q3 24
$-25.9M
Q2 24
$-27.2M
Q1 24
$-7.2M
Q4 23
$19.8M
Operating Margin
ACLX
ACLX
LSBK
LSBK
Q3 25
38.4%
Q2 25
33.2%
Q1 25
-847.6%
Q4 24
-348.2%
Q3 24
-129.1%
Q2 24
-127.8%
Q1 24
-40.3%
Q4 23
23.8%
Net Margin
ACLX
ACLX
LSBK
LSBK
Q3 25
31.8%
Q2 25
27.7%
Q1 25
-766.0%
Q4 24
-308.4%
Q3 24
-99.4%
Q2 24
-99.3%
Q1 24
-18.3%
Q4 23
31.4%
EPS (diluted)
ACLX
ACLX
LSBK
LSBK
Q3 25
$0.32
Q2 25
$0.34
Q1 25
$-1.13
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14
Q4 23
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
LSBK
LSBK
Cash + ST InvestmentsLiquidity on hand
$543.3M
$83.6M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$416.9M
$139.3M
Total Assets
$648.1M
$742.8M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
LSBK
LSBK
Q3 25
$83.6M
Q2 25
$75.4M
Q1 25
$543.3M
Q4 24
$587.4M
Q3 24
$574.3M
Q2 24
$516.7M
Q1 24
$573.9M
Q4 23
$702.0M
Total Debt
ACLX
ACLX
LSBK
LSBK
Q3 25
$2.0M
Q2 25
$2.0M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
ACLX
ACLX
LSBK
LSBK
Q3 25
$139.3M
Q2 25
$92.9M
Q1 25
$416.9M
Q4 24
$454.8M
Q3 24
$483.0M
Q2 24
$487.2M
Q1 24
$496.6M
Q4 23
$485.4M
Total Assets
ACLX
ACLX
LSBK
LSBK
Q3 25
$742.8M
Q2 25
$734.8M
Q1 25
$648.1M
Q4 24
$711.3M
Q3 24
$764.9M
Q2 24
$734.3M
Q1 24
$779.7M
Q4 23
$825.1M
Debt / Equity
ACLX
ACLX
LSBK
LSBK
Q3 25
0.01×
Q2 25
0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
LSBK
LSBK
Operating Cash FlowLast quarter
$-63.1M
$3.3M
Free Cash FlowOCF − Capex
$-63.9M
$3.3M
FCF MarginFCF / Revenue
-786.4%
44.4%
Capex IntensityCapex / Revenue
9.6%
0.6%
Cash ConversionOCF / Net Profit
1.42×
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
LSBK
LSBK
Q3 25
$3.3M
Q2 25
$2.5M
Q1 25
$-63.1M
Q4 24
$-46.0M
Q3 24
$30.7M
Q2 24
$-36.2M
Q1 24
$-31.9M
Q4 23
$58.2M
Free Cash Flow
ACLX
ACLX
LSBK
LSBK
Q3 25
$3.3M
Q2 25
$2.0M
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
Q4 23
$53.0M
FCF Margin
ACLX
ACLX
LSBK
LSBK
Q3 25
44.4%
Q2 25
28.5%
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Q4 23
83.9%
Capex Intensity
ACLX
ACLX
LSBK
LSBK
Q3 25
0.6%
Q2 25
7.7%
Q1 25
9.6%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%
Q4 23
8.4%
Cash Conversion
ACLX
ACLX
LSBK
LSBK
Q3 25
1.42×
Q2 25
1.31×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
2.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons